TD Asset Management
IONS icon

TD Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

TD Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27M Sell
340,548
-189,406
-36% -$14.3M 0.02% 439
2026
Q1 		$39.8M Sell
529,954
-243,230
-31% -$19.2M 0.03% 368
2025
Q4 		$61.2M Sell
773,184
-187,088
-19% -$14.1M 0.05% 276
2025
Q3 		$62.8M Sell
960,272
-144,418
-13% -$7.05M 0.05% 275
2025
Q2 		$43.6M Buy
1,104,690
+4,224
+0.4% +$138K 0.04% 351
2025
Q1 		$33.2M Buy
1,100,466
+50,476
+5% +$1.65M 0.03% 395
2024
Q4 		$36.7M Sell
1,049,990
-43,000
-4% -$1.61M 0.03% 376
2024
Q3 		$44.6M Buy
1,092,990
+140,228
+15% +$6.52M 0.04% 330
2024
Q2 		$45.4M Buy
952,762
+54,400
+6% +$2.23M 0.04% 309
2024
Q1 		$38.9M Sell
898,362
-58,490
-6% -$2.79M 0.04% 343
2023
Q4 		$48.4M Buy
956,852
+58,000
+6% +$2.78M 0.05% 296
2023
Q3 		$40.8M Buy
898,852
+113,644
+14% +$4.69M 0.05% 289
2023
Q2 		$32.2M Sell
785,208
-32,100
-4% -$1.23M 0.04% 346
2023
Q1 		$29.2M Buy
817,308
+37,813
+5% +$1.42M 0.04% 355
2022
Q4 		$29.4M Sell
779,495
-24,588
-3% -$1.03M 0.04% 355
2022
Q3 		$35.6M Buy
804,083
+419
+0.1% +$17.7K 0.04% 305
2022
Q2 		$29.8M Sell
803,664
-16,500
-2% -$622K 0.03% 344
2022
Q1 		$30.4M Buy
820,164
+77,000
+10% +$2.52M 0.03% 391
2021
Q4 		$22.6M Buy
743,164
+321,200
+76% +$10.1M 0.02% 486
2021
Q3 		$14.2M Buy
421,964
+100
+0% +$3.77K 0.01% 568
2021
Q2 		$15.7M Sell
421,864
-2,715
-0.6% -$106K 0.02% 540
2021
Q1 		$19.1M Buy
424,579
+39,235
+10% +$2.19M 0.02% 476
2020
Q4 		$21.8M Buy
385,344
+105,697
+38% +$5.27M 0.03% 420
2020
Q3 		$13.3M Buy
279,647
+72,605
+35% +$4.03M 0.02% 478
2020
Q2 		$12.2M Buy
207,042
+111,277
+116% +$6.19M 0.02% 470
2020
Q1 		$4.53M Buy
95,765
+53,862
+129% +$3M 0.01% 643
2019
Q4 		$2.53M Sell
41,903
-5,200
-11% -$310K ﹤0.01% 878
2019
Q3 		$2.82M Sell
47,103
-1,600
-3% -$104K ﹤0.01% 828
2019
Q2 		$3.13M Sell
48,703
-22,700
-32% -$1.6M ﹤0.01% 812
2019
Q1 		$5.8M Buy
71,403
+49,900
+232% +$3.22M 0.01% 656
2018
Q4 		$1.16M Buy
21,503
+1,900
+10% +$96.9K ﹤0.01% 1023
2018
Q3 		$1.01M Sell
19,603
-2,000
-9% -$94K ﹤0.01% 1160
2018
Q2 		$900K Sell
21,603
-500
-2% -$22.2K ﹤0.01% 1152
2018
Q1 		$974K Sell
22,103
-2,000
-8% -$102K ﹤0.01% 1065
2017
Q4 		$1.21M Buy
24,103
+6,300
+35% +$345K ﹤0.01% 1002
2017
Q3 		$903K Sell
17,803
-997
-5% -$52.2K ﹤0.01% 1058
2017
Q2 		$956K Sell
18,800
-13,300
-41% -$619K ﹤0.01% 1055
2017
Q1 		$1.29M Sell
32,100
-1,500
-4% -$67.4K ﹤0.01% 980
2016
Q4 		$1.61M Buy
33,600
+23,900
+246% +$946K ﹤0.01% 913
2016
Q3 		$355K Sell
9,700
-10,420
-52% -$326K ﹤0.01% 1266
2016
Q2 		$469K Buy
20,120
+1,620
+9% +$52.3K ﹤0.01% 1131
2016
Q1 		$749K Hold
18,500
– – ﹤0.01% 1023
2015
Q4 		$1.15M Buy
18,500
+2,100
+13% +$113K ﹤0.01% 932
2015
Q3 		$663K Hold
16,400
– – ﹤0.01% 1017
2015
Q2 		$944K Buy
16,400
+1,300
+9% +$82.7K ﹤0.01% 967
2015
Q1 		$961K Sell
15,100
-39,700
-72% -$2.69M ﹤0.01% 954
2014
Q4 		$3.38M Buy
54,800
+900
+2% +$44.4K 0.01% 757
2014
Q3 		$2.09M Buy
53,900
+1,100
+2% +$39K ﹤0.01% 818
2014
Q2 		$1.82M Sell
52,800
-18,500
-26% -$583K ﹤0.01% 840
2014
Q1 		$3.08M Buy
71,300
+500
+0.7% +$24.2K 0.01% 760
2013
Q4 		$2.82M Buy
70,800
+3,700
+6% +$132K 0.01% 762
2013
Q3 		$2.52M Sell
67,100
-4,900
-7% -$146K 0.01% 763
2013
Q2 		$1.94M Buy
+72,000
New +$1.53M ﹤0.01% 770

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

TD Asset Management's IONS Position: Q2 2026 in Review

TD Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 36% in Q2 2026, selling an estimated $14.3M and leaving 340,548 shares worth $27M. The position accounts for 0.02% of the portfolio, ranked #439.

TD Asset Management first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. The position peaked at $62.8M in Q3 2025. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • TD Asset Management held 340,548 shares of Ionis Pharmaceuticals worth $27M as of Q2 2026.
  • TD Asset Management sold 189,406 Ionis Pharmaceuticals shares in Q2 2026, an estimated $14.3M.
  • Ionis Pharmaceuticals made up 0.02% of TD Asset Management's portfolio in Q2 2026, its #439 holding.
  • TD Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • TD Asset Management's Ionis Pharmaceuticals position peaked at $62.8M in Q3 2025.
  • 375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.